Prognostic factors in head and neck mucoepidermoid carcinoma
- PMID: 14967746
- DOI: 10.1001/archotol.130.2.174
Prognostic factors in head and neck mucoepidermoid carcinoma
Abstract
Objective: To analyze clinical, histological, and immunohistochemical prognostic factors in a large series of patients with mucoepidermoid carcinoma (MEC) treated in a single institution, using univariate and multivariate survival analyses.
Design: Inception cohort.
Setting: Referral center.
Patients: All patients diagnosed with head and neck MEC from a single cancer referral center from January 19, 1957, to July 12, 1997.
Main outcome measures: Rates of local recurrence, regional and distant metastasis, and overall actuarial survival.
Results: Men represented 53.8% of the cohort, and the parotid gland and palate were affected by MEC in 35.2% and 23.7%, respectively. TNM stage I or II lesions comprised 50.3% of the tumors, and low-grade tumors comprised 45.2%, and the 5-year overall survival was 70.2%. Univariate survival analysis revealed that age older than 40 years (P<.001), male sex (P=.005), fixed tumors (P=.002), invasion of adjacent structures (P=.004), T stage (P<.001), N stage (P<.001), clinical stage (P<.001), histological grade (P<.001), and expression of proliferating cell nuclear antigen (P<.001), Ki-67 (P<.001), and p53 (P<.001) correlated with a poor prognosis. Expression of carcinoembryonic antigen (P=.01) and bcl-2 (P<.001) correlated with a better prognosis.
Conclusion: Age older than 40 years, fixed tumors, T and N stage, and histological grade are independent significant prognostic factors in patients with MEC.
Similar articles
-
Clinical prognostic factors in malignant parotid gland tumors.Otolaryngol Head Neck Surg. 2005 Nov;133(5):702-8. doi: 10.1016/j.otohns.2005.08.001. Otolaryngol Head Neck Surg. 2005. PMID: 16274796
-
Prognostic factors in head and neck adenoid cystic carcinoma.Oral Oncol. 2006 Feb;42(2):139-46. doi: 10.1016/j.oraloncology.2005.06.024. Epub 2005 Oct 24. Oral Oncol. 2006. PMID: 16249115
-
Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.Cancer. 2007 Nov 15;110(10):2253-9. doi: 10.1002/cncr.23048. Cancer. 2007. PMID: 17918258
-
Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature.Oral Dis. 2006 Jul;12(4):364-70. doi: 10.1111/j.1601-0825.2005.01166.x. Oral Dis. 2006. PMID: 16792720 Review.
-
Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Ear Nose Throat J. 2008. PMID: 19006065 Review.
Cited by
-
Expression of Mucins in Salivary Gland Mucoepidermoid Carcinoma.Head Neck Pathol. 2021 Jun;15(2):491-502. doi: 10.1007/s12105-020-01226-z. Epub 2020 Sep 21. Head Neck Pathol. 2021. PMID: 32959209 Free PMC article.
-
Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management.Cancers (Basel). 2022 Dec 30;15(1):250. doi: 10.3390/cancers15010250. Cancers (Basel). 2022. PMID: 36612247 Free PMC article.
-
Expression of mucin (MUC) genes in mucoepidermoid carcinoma.Laryngoscope. 2011 Jan;121(1):167-70. doi: 10.1002/lary.21164. Laryngoscope. 2011. PMID: 21072847 Free PMC article.
-
MRI findings of mucoepidermoid carcinoma of the parotid gland: correlation with pathological features.Br J Radiol. 2012 Jun;85(1014):709-13. doi: 10.1259/bjr/55639432. Epub 2011 Sep 6. Br J Radiol. 2012. PMID: 21896663 Free PMC article.
-
2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors.Int J Mol Sci. 2021 Jun 24;22(13):6771. doi: 10.3390/ijms22136771. Int J Mol Sci. 2021. PMID: 34202474 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
